Debevoise Advises Clayton, Dubilier & Rice in Its Acquisition of Drive DeVilbiss Healthcare

30 August 2016

Debevoise & Plimpton LLP is advising Clayton, Dubilier & Rice (“CD&R”) in acquiring a controlling stake, alongside existing management, in Drive DeVilbiss Healthcare (“Drive”), a global manufacturer of medical products.

Formed in 2000, Drive has become a leading manufacturer of medical products with a strong and consistent track record of growth achieved both organically and through acquisitions. The company’s high-quality, diverse product portfolio, channel footprint and global operating scale were strategically built by its executive leadership team to take advantage of favorable underlying demographic and industry trends. Drive’s products include a full suite of mobility, respiratory, sleep, bath and personal care, specialty beds, pressure prevention, rehabilitation and other related products, and are primarily sold into the homecare channel. Drive serves a customer base of more than 15,000 dealers, home healthcare providers, healthcare distributors, retailers and e-commerce companies and sells its branded products in more than 80 countries around the world.

Founded in 1978, Clayton, Dubilier & Rice invests in European and U.S-based businesses. Since inception, CD&R has managed the investment of $22 billion in 70 companies representing a broad range of industries with an aggregate transaction value of approximately $100 billion.

The Debevoise team is led by partner Kevin A. Rinker, and includes partners Andrew A. Bab, Peter L. Furci, Meir D. Katz, Scott B. Selinger, and counsel Judith L. Church, and associates Tomer S. Dorfan, Andrew G. Jamieson, Ross Liemer, Rebecca Quan, Christian C. Richter and Lauren M. Sirois.

Debevoise & Plimpton LLP is a premier law firm with market-leading practices, a global perspective and strong New York roots. We deliver effective solutions to our clients’ most important legal challenges, applying clear commercial judgment and a distinctively collaborative approach.